Reviewed By Ray Spotts
A new pre-clinical study – co-lead by UCLA researchers - could prevent patients treated for cancer or osteoporosis from experiencing jawbone damage as a result of oral surgery. Bisphosphonates are currently used to treat patients who have bone cancer or osteoporosis. These drugs bind to the skeleton and prevent a loss in bone density and remain bound to bones for months or even years after initial treatment.
